{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:22:40Z","timestamp":1786501360508,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T00:00:00Z","timestamp":1477353600000},"content-version":"am","delay-in-days":329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE-1311230"],"award-info":[{"award-number":["DGE-1311230"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009797","name":"Barrow Neurological Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-14-1-0311"],"award-info":[{"award-number":["W81XWH-14-1-0311"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA149128"],"award-info":[{"award-number":["R01-CA149128"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-DA022975"],"award-info":[{"award-number":["T32-DA022975"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008222","name":"Ben and Catherine Ivy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008222","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jconrel.2015.10.013","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T08:38:16Z","timestamp":1445762296000},"page":"89-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"PA","title":["A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9009-9937","authenticated-orcid":false,"given":"Rebecca L.","family":"Cook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle T.","family":"Householder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene P.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alesia V.","family":"Prakapenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"DiPerna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9196-0239","authenticated-orcid":false,"given":"Rachael W.","family":"Sirianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2015.10.013_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2217\/cns.14.2","article-title":"Nanocarrier-based therapies for CNS tumors","volume":"3","author":"Patel","year":"2014","journal-title":"CNS Oncol."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1166\/jnn.2014.8757","article-title":"Functional nanoparticles in targeting glioma diagnosis and therapies","volume":"14","author":"Li","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2174\/1567201810666140106115436","article-title":"The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems","volume":"11","author":"Tortorella","year":"2014","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0020","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.addr.2013.08.012","article-title":"Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status","volume":"65","author":"van der Meel","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","article-title":"Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?","volume":"71","author":"Kreuter","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejps.2010.05.003","article-title":"Strategy for effective brain drug delivery","volume":"40","author":"Alam","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0035","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/0008-5472.CAN-12-4561","article-title":"Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology","volume":"73","author":"Prabhakar","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0040","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijpharm.2015.01.002","article-title":"Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma","volume":"479","author":"Householder","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0050","doi-asserted-by":"crossref","first-page":"37655","DOI":"10.1074\/jbc.M201374200","article-title":"Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor","volume":"277","author":"Langevin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/13550280590900427","article-title":"Rabies virus receptors","volume":"11","author":"Lafon","year":"2005","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2015.10.013_bb0065","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","article-title":"Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles","volume":"30","author":"Liu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.10.013_bb0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2010.08.011","article-title":"RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain","volume":"155","author":"Son","year":"2011","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0075","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1016\/j.biomaterials.2011.03.047","article-title":"A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA","volume":"32","author":"Hwang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.10.013_bb0080","doi-asserted-by":"crossref","first-page":"e62905","DOI":"10.1371\/journal.pone.0062905","article-title":"Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson\u2019s Disease","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jconrel.2015.10.013_bb0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12017-012-8196-8","article-title":"RVG-Mediated Calpain2 Gene Silencing in the Brain Impairs Learning and Memory","volume":"15","author":"Zadran","year":"2012","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0090","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.biomaterials.2012.09.047","article-title":"Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.10.013_bb0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jconrel.2012.09.001","article-title":"Targeted imaging of activated caspase-3 in the central nervous system by a dual functional nano-device","volume":"163","author":"Liu","year":"2012","journal-title":"J. Control Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0100","doi-asserted-by":"crossref","first-page":"11808","DOI":"10.1039\/c2jm31675g","article-title":"Brain-targeting gene delivery using a rabies virus glycoprotein peptide modulated hollow liposome: bio-behavioral study","volume":"22","author":"Tao","year":"2012","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0110","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3109\/1061186X.2010.523788","article-title":"Targeted delivery of large fusion protein into hippocampal neurons by systemic administration","volume":"19","author":"Xiang","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0115","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1007\/s11095-012-0667-y","article-title":"Targeted Delivery of Proteins into the Central Nervous System Mediated by Rabies Virus Glycoprotein-Derived Peptide","volume":"29","author":"Fu","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/1061186X.2010.492523","article-title":"Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles","volume":"19","author":"Chen","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0125","first-page":"51015","article-title":"PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS","volume":"82","author":"McCall","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0130","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1016\/j.biomaterials.2005.02.025","article-title":"Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting","volume":"26","author":"Fahmy","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.10.013_bb0135","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1021\/bc800057g","article-title":"Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells","volume":"19","author":"McCarron","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0140","first-page":"22","article-title":"Evaluation of antimetastatic activity and systemic toxicity of camptothecin-loaded microspheres in mice injected with B16-F10 melanoma cells","volume":"9","author":"Dora","year":"2006","journal-title":"J. Pharm. Pharm. Sci. Publ. Can. Soc. Pharm. Sci. Soci\u00e9t\u00e9 Can. Sci. Pharm."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/10520298109067317","article-title":"A rapid method for removal of the spinal cord","volume":"56","author":"Meikle","year":"1981","journal-title":"Stain. Technol."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0150","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.neuroimage.2009.03.083","article-title":"Measurement of cerebral blood volume in mouse brain regions using micro-computed tomography","volume":"47","author":"Chugh","year":"2009","journal-title":"NeuroImage"},{"key":"10.1016\/j.jconrel.2015.10.013_bb0155","doi-asserted-by":"crossref","first-page":"e00063","DOI":"10.1042\/AN20110014","article-title":"Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model","volume":"3","author":"Jacobs","year":"2011","journal-title":"ASN Neuro."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0160","first-page":"e3404","article-title":"Intracranial Implantation with Subsequent 3D In Vivo Bioluminescent Imaging of Murine Gliomas","volume":"57","author":"Abdelwahab","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0165","first-page":"53","article-title":"Adsorption of plasma proteins on uncoated PLGA nanoparticles","volume":"85","author":"Sempf","year":"2013","journal-title":"Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft F\u00fcr Pharm. Verfahrenstechnik EV."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0170","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1046\/j.1460-9568.2002.01967.x","article-title":"Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat","volume":"15","author":"Calvo","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0175","doi-asserted-by":"crossref","first-page":"e944449","DOI":"10.4161\/21688362.2014.944449","article-title":"Pathogen-inspired drug delivery to the central nervous system","volume":"2","author":"McCall","year":"2014","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.jconrel.2015.10.013_bb0180","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/nn505980z","article-title":"Nanocarrier-mediated inhibition of macrophage migration inhibitory factor attenuates secondary injury after spinal cord injury","volume":"9","author":"Saxena","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2015.10.013_bb0185","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1016\/j.biomaterials.2008.07.050","article-title":"Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury","volume":"29","author":"Wang","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.10.013_bb0190","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.biomaterials.2008.01.002","article-title":"Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord","volume":"29","author":"Chvatal","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.10.013_bb0195","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/nnano.2014.274","article-title":"Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury","volume":"9","author":"Gaudin","year":"2014","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0200","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.22421","article-title":"The blood-spinal cord barrier: morphology and clinical implications","volume":"70","author":"Bartanusz","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0205","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0306-4522(87)90098-4","article-title":"GABAA and GABAB receptor site distribution in the rat central nervous system","volume":"20","author":"Bowery","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/j.jconrel.2015.10.013_bb0210","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2165\/00003495-200262140-00004","article-title":"Camptothecins: a review of their chemotherapeutic potential","volume":"62","author":"Ulukan","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2015.10.013_bb0215","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1021\/bc500315j","article-title":"Radiolabeling of poly(lactic-co-glycolic acid) (PLGA) nanoparticles with biotinylated F-18 prosthetic groups and imaging of their delivery to the brain with positron emission tomography","volume":"25","author":"Sirianni","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0220","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.1073\/pnas.1304504110","article-title":"Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma","volume":"110","author":"Zhou","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0225","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1021\/mp800137z","article-title":"Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited","volume":"6","author":"Xu","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0230","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jconrel.2013.06.014","article-title":"A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging","volume":"170","author":"Bastiat","year":"2013","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0235","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1073\/pnas.0707046105","article-title":"Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2015.10.013_bb0240","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2012.04.042","article-title":"Beyond the imaging: limitations of cellular uptake study in the evaluation of nanoparticles","volume":"164","author":"Gullotti","year":"2012","journal-title":"J. Control. Release Off. J. Control. Release Soc."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915301814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915301814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:31:00Z","timestamp":1759159860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365915301814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":48,"alternative-id":["S0168365915301814"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.10.013","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}